Created at Source Raw Value Validated value
Feb. 6, 2022, 2 p.m. usa

Antigen-specific stimulation of peripheral blood mononuclear cells in vitro;B lymphocytes;Chemiluminescence serological assay for qualitative and quantitative determination of neutralizing antibodies against Spike protein (anti-SARS-Cov-2 anti-IgG-S);Dosage of systemic soluble factors;intracytoplasmic cytokines;Serological assay by chemiluminescence for qualitative and quantitative determination of specific IgG antibodies against the nucleocapsid protein of SARS-Cov-2;T lymphocytes;Viral neutralization assay

Antigen-specific stimulation of peripheral blood mononuclear cells in vitro;B lymphocytes;Chemiluminescence serological assay for qualitative and quantitative determination of neutralizing antibodies against Spike protein (anti-SARS-Cov-2 anti-IgG-S);Dosage of systemic soluble factors;intracytoplasmic cytokines;Serological assay by chemiluminescence for qualitative and quantitative determination of specific IgG antibodies against the nucleocapsid protein of SARS-Cov-2;T lymphocytes;Viral neutralization assay